EVMT — Evome Medical Technologies Balance Sheet
0.000.00%
- CA$0.42m
- CA$16.47m
- CA$62.63m
- 51
- 86
- 16
- 50
Annual balance sheet for Evome Medical Technologies, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2019 February 28th | R2020 February 29th | 2021 February 28th | 2022 February 28th | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 9.3 | 9.19 | 7.57 | 8.06 | 0.919 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 1.53 | 0.397 | 0 | 6.6 | 7.8 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 11.4 | 9.73 | 13.1 | 20 | 21 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.187 | — | — | 5.4 | 13.1 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 11.6 | 9.73 | 13.1 | 42.7 | 48.3 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.394 | 0.217 | 6.47 | 23.2 | 37.6 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 0.409 | 0.232 | 6.49 | 29.5 | 44.3 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 11.2 | 9.5 | 6.64 | 13.2 | 4 |
Total Liabilities & Shareholders' Equity | 11.6 | 9.73 | 13.1 | 42.7 | 48.3 |
Total Common Shares Outstanding |